4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-25-000028
President and CEO acquired 54,180 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-03 | Grant or award : show line 1 in the form | +54,180 | 289,987 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-03 | Grant or award : show line 2 in the form Stock Option (right to buy) | +162,540 | 162,540 | D |
Loading xslF345X05/wk-form4_1736294379.xml…